Læknablaðið - 01.02.1978, Side 59

HSLCIDeRm
topical halcinonide 0.11
in dermatology
-anew
corticosteroid
-aunique
bi-phasic base
giving controlled
potency for
prolonged activity
advanced aPproa ° síí,n freatment
• immediate penetration
• sustained activity
• excellent results in eczema
• significantly better
than betamethasone
17 valerate in the treatment
of psoriasis.
SQUIBB
Further information on request: E. R. Squibb and Sons Limitea Pe::.; H use i v. ickenham, TW1 3QT.